SARS-CoV-2 expresses a microRNA-like small RNA able to selectively repress host genes.

Area of Science:

• Virology
• Molecular Biology
• Genetics

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a significant global health issue.
• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression, crucial in viral infections.
• Understanding host-pathogen interactions at the molecular level is vital for therapeutic development.

Purpose of the Study:

• To investigate the impact of SARS-CoV-2 infection on host miRNA profiles in lung cells and clinical samples.
• To identify and characterize any novel small RNAs produced during SARS-CoV-2 infection.

Main Methods:

• Analysis of miRNA populations in SARS-CoV-2-infected human lung cell lines and nasopharyngeal swabs.
• Identification and characterization of viral small RNAs, including their association with Argonaute proteins.
• Prediction and validation of target genes for identified viral small RNAs.

Main Results:

• No significant alterations in host miRNA levels were observed post-SARS-CoV-2 infection.
• A novel viral miRNA-like small RNA, CoV2-miR-O7a, derived from the ORF7a gene, was identified.
• CoV2-miR-O7a associates with Argonaute proteins and targets host genes, including BATF2 involved in interferon signaling.
• Production of CoV2-miR-O7a depends on cellular machinery but not Drosha, and is enhanced by a conserved hairpin in ORF7a.

Conclusions:

• SARS-CoV-2 infection does not drastically alter host miRNA expression.
• The virus produces a unique miRNA-like small RNA (CoV2-miR-O7a) that may modulate host responses.
• CoV2-miR-O7a's interaction with the RNA interference pathway and its potential to regulate host genes warrants further investigation.